To date, ecabet sodium is the only commercial drug based on abietane-type diterpenoids which is clinically used in the treatment of gastritis and gastric ulcers in Japan since it possesses high affinity to gastric adherent mucosa, epithelial cells, albumin, and fibrinogen in the ulcer region [48]. The gene discussed is ALB; the disease is gastritis.